Lung Therapeutics, Inc., 10% Owner at TFF Pharmaceuticals, Inc. (TFFP), sold 715,000 shares at $14.00 ($10.0M) on 2021-03-26, disclosed to the SEC on 2021-03-30.
Open-market sale of $10.0M TFFP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.